These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3869230)

  • 1. [Effect of the composition of the reversion medium on the transformation of coccal forms and L-form of Staphylococcus aureus lysostaphin protoplasts].
    Kato Y; Hirachi Y; Toda Y; Kurono M; Takemasa N; Kotani S
    Osaka Daigaku Shigaku Zasshi; 1985 Dec; 30(2):296-303. PubMed ID: 3869230
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the composition of reversion medium on change of Staphylococcus aureus lysostaphin protoplasts to coccal forms and L-forms.
    Kato Y; Hirachi Y; Toda Y; Takemasa N; Kotani S
    Biken J; 1986 Jun; 29(2):39-44. PubMed ID: 3814073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell fusion between L-forms and protoplasts of Staphylococcus aureus.
    Hirachi Y; Kato Y; Toda Y; Takemasa N; Kotani S
    Biken J; 1985 Dec; 28(3-4):59-70. PubMed ID: 3834926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of L-phase variant from protoplast of Staphylococcus aureus.
    Makino T
    Microbiol Immunol; 1983; 27(9):749-55. PubMed ID: 6645987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcal spheroplasts and L-colonies. 3. Induction by lysostaphin.
    Watanakunakorn C; Goldberg LM; Carleton J; Hamburger M
    J Infect Dis; 1969 Jan; 119(1):67-74. PubMed ID: 5765044
    [No Abstract]   [Full Text] [Related]  

  • 6. Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization.
    Shah A; Mond J; Walsh S
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2704-7. PubMed ID: 15215130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internally quenched peptides for the study of lysostaphin: An antimicrobial protease that kills Staphylococcus aureus.
    Warfield R; Bardelang P; Saunders H; Chan WC; Penfold C; James R; Thomas NR
    Org Biomol Chem; 2006 Oct; 4(19):3626-38. PubMed ID: 16990938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of various blood culture media on lysostaphin sensitivity of staphylococci.
    Severance PJ; Kauffman CA; Sheagren JN
    J Clin Microbiol; 1980 Nov; 12(5):709-10. PubMed ID: 7276143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin.
    Francius G; Domenech O; Mingeot-Leclercq MP; Dufrêne YF
    J Bacteriol; 2008 Dec; 190(24):7904-9. PubMed ID: 18835985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of osmotic stabilizer on protoplasts and bacterial forms of Streptococcus faecalis.
    Montgomerie JZ; Kalmanson GM; Guze LB
    J Lab Clin Med; 1967 Oct; 70(4):539-53. PubMed ID: 4964048
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of phagocytosis of 32P-labeled Staphylococcus aureus by bovine polymorphonuclear leukocytes.
    Dulin AM; Paape MJ; Weinland BT
    Am J Vet Res; 1984 Apr; 45(4):786-9. PubMed ID: 6731995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal spheroplasts and L colonies. IV. Antimicrobial susceptibility of stable methicillin-induced and lysostaphin-induced spheroplasts.
    Watanakunakorn C; Goldberg LM; Carleton J; Hamburger M
    Antimicrob Agents Chemother (Bethesda); 1968; 8():382-7. PubMed ID: 5195739
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of phagocytosis of Staphylococcus aureus with the aid of lysostaphin (author's transl)].
    Dörner I; Blobel H; Schaeg W
    Zentralbl Bakteriol Orig A; 1977; 237(2-3):141-6. PubMed ID: 848206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysostaphin-induced, osmotically fragile Staphylococcus aureus cells.
    Huber TW; Schuhardt VT
    J Bacteriol; 1970 Jul; 103(1):116-9. PubMed ID: 5423366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Chimeric LysK-Lysostaphin Fusion Enzyme Lysing Staphylococcus aureus Cells: a Study of Both Kinetics of Inactivation and Specifics of Interaction with Anionic Polymers.
    Filatova LY; Donovan DM; Ishnazarova NT; Foster-Frey JA; Becker SC; Pugachev VG; Balabushevich NG; Dmitrieva NF; Klyachko NL
    Appl Biochem Biotechnol; 2016 Oct; 180(3):544-557. PubMed ID: 27168405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin.
    Graham S; Coote PJ
    J Antimicrob Chemother; 2007 Apr; 59(4):759-62. PubMed ID: 17324959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysostaphin: an antistaphylococcal agent.
    Kumar JK
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osmotic fragility and viability of lysostaphin-induced staphylococcal spheroplasts.
    Schuhardt VT; Klesius PH
    J Bacteriol; 1968 Sep; 96(3):734-7. PubMed ID: 5732506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus.
    LaPlante KL
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):413-8. PubMed ID: 17141452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of lysostaphin to remove cell-adherent staphylococci during in vitro assays of phagocyte function.
    Easmon CS; Lanyon H; Cole PJ
    Br J Exp Pathol; 1978 Aug; 59(4):381-5. PubMed ID: 708586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.